Electronic relaxation device: improvement of patient discomfort
This study aims to evaluate the effectiveness of various electronic relaxation devices in reducing stress-related symptoms often reported in the intensive care unit (ICU). A randomized crossover approach was used to recruit 60 critically ill patients in 4 relaxation sessions: traditional relaxation (TV/radio), music therapy (MUSIC-CARE©) and 2 virtual reality systems using either real movies (DEEPSEN©) or synthetic films (HEALTHY-MIND). The primary objective was to compare devices based on their ability to reduce patient discomfort, as measured by a Numerical Rating Scale (NRS) from 0 to 10. The Analgesia/Nociception Index (ANI) was was used to assess stress response, and secondary endpoints included the presence of particular stress symptoms (pain, anxiety, dyspnea, thirst, and a general feeling of being unrested). In this study, researchers used multivariate mixed-effects analysis to examine the relationship between patient characteristics and various variables. Approximately 50 patients completed the entire study and 10 patients participated in at least 1 relaxation session as part of the study. A decrease in the stress response (increase in the ANI, secondary endpoint; P=0.01) and a decrease in overall discomfort (median NRS = 4[2-6] against 2[0-5]; PPP=0.001) and DEEPSEN© linked to a reduction in fatigue (P=0.01). In a study of 109 virtual reality sessions, 3 occurrences (claustrophobia, dyspnea and agitation) were reported. As indicated by the NRS = 0[0-0], cybersickness was rare. The use of electronic relaxation therapy for pain relief in critical care patients who are awake and non-delirious is an exciting new area of research that is showing great promise as a safe and effective non-pharmacological alternative to traditional methods. of pain relief. The type of symptoms treated and the specifics of the treatment itself (virtual reality with a synthetic imaginary environment against the real world or music therapy without virtual reality) determine its effectiveness.
Source: ccforum.biomedcentral.com/articles/10.1186/s13054-022-04136-4
Comments are closed.